Clover Health Inv Stock Price To Sales
| 7QD Stock | 3.17 0.16 5.32% |
CLOVER HEALTH INV fundamentals help investors to digest information that contributes to CLOVER HEALTH's financial success or failures. It also enables traders to predict the movement of CLOVER Stock. The fundamental analysis module provides a way to measure CLOVER HEALTH's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CLOVER HEALTH stock.
CLOVER |
CLOVER HEALTH INV Company Price To Sales Analysis
CLOVER HEALTH's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, CLOVER HEALTH INV has a Price To Sales of 0.0 times. This is 100.0% lower than that of the Healthcare sector and about the same as Healthcare Plans (which currently averages 0.0) industry. The price to sales for all Germany stocks is 100.0% higher than that of the company.
CLOVER Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CLOVER HEALTH's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CLOVER HEALTH could also be used in its relative valuation, which is a method of valuing CLOVER HEALTH by comparing valuation metrics of similar companies.CLOVER HEALTH is currently under evaluation in price to sales category among its peers.
CLOVER Fundamentals
| Return On Equity | -1.1 | |||
| Return On Asset | -0.22 | |||
| Profit Margin | (0.15) % | |||
| Operating Margin | (0.14) % | |||
| Shares Outstanding | 383.55 M | |||
| Shares Owned By Insiders | 13.15 % | |||
| Shares Owned By Institutions | 32.44 % | |||
| Revenue | 3.04 B | |||
| Gross Profit | (189.81 M) | |||
| EBITDA | (437.49 M) | |||
| Book Value Per Share | 0.82 X | |||
| Earnings Per Share | (1.34) X | |||
| Target Price | 9.0 | |||
| Number Of Employees | 680 | |||
| Beta | 1.93 | |||
| Market Capitalization | 548.87 M |
About CLOVER HEALTH Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CLOVER HEALTH INV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CLOVER HEALTH using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CLOVER HEALTH INV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in CLOVER Stock
CLOVER HEALTH financial ratios help investors to determine whether CLOVER Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CLOVER with respect to the benefits of owning CLOVER HEALTH security.